Fischer Medical Ventures Intrinsic Value
Fischer Medical Ventures (FISCHER) median intrinsic value is ₹59.23 from 2 valuation models (range ₹48–₹59), vs current price ₹33.15 — +78.7% upside (Trading Below Calculated Value), margin of safety 44.0%. Check Fischer Medical Ventures marketcap in USD to track the company's total market size over time.
FISCHER Valuation Methods Summary — DCF, Graham Number & P/E
Fischer Medical Ventures intrinsic value across 2 models vs current price ₹33.15 — upside/downside and value range per method. For current market price and key ratios, visit Fischer Medical Ventures share price today.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹59.23 | ₹53.31 - ₹65.15 | +78.7% | Book Value/Share: ₹59.23, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹48.25 | ₹43.43 - ₹53.08 | +45.6% | Revenue/Share: ₹60.31, P/S: 0.8x |
FISCHER Intrinsic Value vs Market Price — All Valuation Models
Fischer Medical Ventures fair value range ₹48–₹59 vs current market price ₹33.15 across 2 valuation models. See FISCHER book value comparison to compare market price against book value per share.
FISCHER Intrinsic Value Analysis — Undervalued or Overvalued?
Fischer Medical Ventures median intrinsic value ₹59.23, current price ₹33.15 — Trading Below Calculated Value by 78.7%, margin of safety 44.0%.
What is the intrinsic value of FISCHER?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Fischer Medical Ventures (FISCHER) is ₹59.23 (median value). With the current market price of ₹33.15, this represents a +78.7% variance from our estimated fair value.
The valuation range spans from ₹48.25 to ₹59.23, indicating ₹48.25 - ₹59.23.
Is FISCHER undervalued or overvalued?
Based on our multi-method analysis, Fischer Medical Ventures (FISCHER) appears to be trading below calculated value by approximately 78.7%.
FISCHER Financial Health — Key Ratios vs Industry Benchmarks
Fischer Medical Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 15.33 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -12.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.58x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
FISCHER Cash Flow Quality — Operating & Free Cash Flow
Fischer Medical Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-87 Cr | ₹-150 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-7 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |